Back
Biomea Fusion Vs. Syndax Pharmaceuticals Industry Stock Comparison
Sell
18
BMEA
Biomea Fusion
Last Price:
8.18
Seasonality Move:
9.6%
Buy
55
SNDX
Syndax Pharmaceuticals
Last Price:
21.79
Seasonality Move:
11.8%
Sell
18
Biomea Fusion (BMEA)
is a Sell
Is Biomea Fusion a Buy, Sell or Hold?
- The current Biomea Fusion [BMEA] share price is $8.18. The Score for BMEA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- BMEA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Syndax Pharmaceuticals (SNDX)
is a Buy
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $21.81. The Score for SNDX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SNDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMEA Stock Price Chart
What is Biomea Fusion's stock price today?
-
The Biomea Fusion share price today is $8.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMEA is experiencing slight selling pressure.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $21.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNDX is experiencing slight buying pressure.
BMEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 32.99 | Sell |
| Chaikin Money Flow: | -211880 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.3 - 11.76) | Sell |
| Bollinger Bands (100): | (5.16 - 9.8) | Buy |
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 72.12 | Buy |
| Chaikin Money Flow: | 370391 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.39 - 20.29) | Buy |
| Bollinger Bands (100): | (18.5 - 21.94) | Buy |
BMEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.97 | Sell |
| 20-day SMA: | 10.46 | Sell |
| 50-day SMA: | 9.43 | Sell |
| 200-day SMA: | 10.56 | Sell |
| 8-day EMA: | 9.08 | Sell |
| 20-day EMA: | 9.81 | Sell |
| 50-day EMA: | 9.4 | Sell |
| 200-day EMA: | 10.21 | Sell |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.01 | Buy |
| 20-day SMA: | 19.58 | Buy |
| 50-day SMA: | 19.12 | Buy |
| 200-day SMA: | 20.98 | Buy |
| 8-day EMA: | 20.44 | Buy |
| 20-day EMA: | 19.73 | Buy |
| 50-day EMA: | 19.56 | Buy |
| 200-day EMA: | 20.16 | Buy |
Biomea Fusion Earnings Growth & BMEA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $0.80 per share.
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.75 per share.
Biomea Fusion Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syndax Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||